Product to be used in occlusive epicutaneous testing for the purpose of demonstrating contact allergy to formaldehyde
AssigneeKabi Pharmacia AB
InventorsKurt Hedegaard, Sten Albrectsen, Jens Hansen
Life of this patent
Estimating the term…
Abstract
A test strip having at least one patch thereon and intended for use in occlusive epicutaneous testing in order to detect contact allergy to formaldehyde. The characteristic feature is that on at least one of the patches the test substance is a reversible N-formaldehyde derivative of succinimide which is formulated in a dry buffered vehicle.
Claims3
A test strip comprising at least one patch thereon containing a test substance which is suitable for use in occlusive epicutaneous testing in order to detect contact allergy to formaldehyde, wherein the test substance on at least one of said at least one patch is a reversible N-formaldehyde derivative of succinimide, said derivative
- (i) having been formulated in a dry vehicle together with a buffer substance that provides a pH-value within 4-10,
- (ii) decomposing in an aqueous solution of pH 9 containing 0.1M of HCO.sub.3.sup.- /CO.sub.3.sup.2-, and a concentration of test substance of 8.times.10 -.sup.4 M at a half life rate of less than 7 hours, and
- (iii) giving substantially no incidence of skin reactions of an allergic or irritative type.
Dependencies are inferred from the claim text.